MedPath

OBS PAKISTAN (PRIVATE) LIMITED

🇵🇰Pakistan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 4
2 (100.0%)

Noroxin Efficacy and Safety Trial

Phase 4
Conditions
Urinary Tract Infections
Interventions
First Posted Date
2018-04-24
Last Posted Date
2018-04-24
Lead Sponsor
OBS Pakistan
Target Recruit Count
1000
Registration Number
NCT03506256

Perception and Knowledge About Menopause Among Pakistani Woman

Completed
Conditions
Menopause
First Posted Date
2018-04-24
Last Posted Date
2018-04-24
Lead Sponsor
OBS Pakistan
Target Recruit Count
910
Registration Number
NCT03506269
Locations
🇵🇰

Dr. Faizan Shaukat, Karachi, Sindh, Pakistan

Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)

Phase 4
Conditions
Chronic Stable Angina
Interventions
First Posted Date
2018-04-03
Last Posted Date
2018-04-03
Lead Sponsor
OBS Pakistan
Target Recruit Count
2000
Registration Number
NCT03486561

Prevalence of Hyperuricemia in Pakistan

Conditions
Hyperuricemia
First Posted Date
2018-03-22
Last Posted Date
2018-03-22
Lead Sponsor
OBS Pakistan
Target Recruit Count
1000
Registration Number
NCT03473444
Locations
🇵🇰

Dr. Abid Naeem, Mirpur, AJK, Pakistan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.